RE:realistic expectations - growth storySmithwicks wrote: 2015
-40 to 80 pharmacy shelf space(western canadian only)
-small chains and mom and pop pharmacys
-all 49 HC approvals
-4 to 10 specialty otc products
- another finiancing at a higher price with retail to fill huge drug orders ($10 million)-last one hopefully
-more western canadian provincial approvals
-revenue 2 to 3 million
-1 or 2 LOI's
- shareprice 1.80 to 2.80
- more board members
-eps minus .01 to .03
- sales team established
2016
-150 to 250 pharmacys
- applications and growth into eastern canada
-10 to 20 specialty otc drugs
- possible growth and talks with rexall and shoppers
-7 to 8 million revenue
-shareprice $3 to $5
-Possible partnerships or growth in Middle East
-eps .05 to .10
- addition board members
-tsx listing
2017
-300 to 450 Pharmacys -dominating western canada
-moving into eastern canada
-10 more generic HC approvals
-15 to 30 specialty otc drugs
-shareprice 10$ to $12
-eps .15 to .25
-revenue $15 $25 million
- takeover target by Us of Canadian companies
There lots of ands ,ifs and buts. Im really trying to undershoot here but was trying create a possible scenerio and trying to be realistic. Please, let me know of other growth oppurtunities or possibilities. Any feedback is welcome. I have a feeling Dart will think ive lost my marbles.
Thanks for your conservative growing of Vanc, but, just two quick reminder; 1- the way this new management team is working, we should be in 500 pharma by this year end. 2- The 10 new HC generics in 2017 are way to far. Remember how long it take to get 30 drugs approved already. These guy have many entries in many direction. Pharma, manufacturing, consultants, South America, India, maybe HC too.... 3 days ago, the NR (that some people here taught was saying nothing new) shows us the rapidity of Vanc intentions....This injection of capital will assist us in two key areas of our Company as it puts us in a position to ramp up our Sales and Marketing team and allows for additional product acquisitions," said Arun Nayyar, CEO of Vanc. "We expect to begin shipping in Q2-2015 and have spent considerable time reviewing several product acquisitions that fit into our existing portfolio of generics and OTC products."......... Additional acquisitions of OTC and generics.... That was what Dart was trying to make everyone see when he mentioned to read closely (or something like that)..... The generics addition shouldn't be long and 3-4 months with HC + 2-3 months manufacturing them and boom.... On the market by Q4/2015......